Biopharmaceutical Manufacturing and the Power of Synthetic Biology: Synthetic biology has advanced the scope and scale with which biologically derived therapeutics can be developed.

Detalles Bibliográficos
Publicado en:BioPharm International Vol. 33; no. 5; pp. 22 - 28
Autor principal: McELROY, DAVID
Formato: Journal Article
Publicado: MJH Life Sciences May2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143167450&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 143167450
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: May2020
      vid: 33
      iid: 5
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        143167450
        143167450
      ppf: 22
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Biopharmaceutical Manufacturing and the Power of Synthetic Biology: Synthetic biology has advanced the scope and scale with which biologically derived therapeutics can be developed.
      aug:
        au: McELROY, DAVID
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N